Abstract: In an illustrative embodiment, automated multi-module cell editing instruments comprising one or more flow-through electroporation devices or modules are provided to automate genome editing in live cells.
Type:
Grant
Filed:
September 14, 2019
Date of Patent:
December 17, 2019
Assignee:
Inscripta, Inc.
Inventors:
Jorge Bernate, Don Masquelier, Phillip Belgrader, Kevin Ness
Abstract: The present disclosure provides instrumentation and automated methods for creating cell surface display libraries, where the cells of the library display engineered peptides on their cell surfaces for identification of binding pairs. The engineered peptides may be displayed using various cell surface display technologies.
Type:
Grant
Filed:
April 24, 2019
Date of Patent:
December 10, 2019
Assignee:
Inscripta, Inc.
Inventors:
Stephen Federowicz, Deanna Church, Michael Graige
Abstract: In an illustrative embodiment, automated multi-module cell editing instruments are provided to automate multiple edits into nucleic acid sequences inside one or more cells.
Type:
Grant
Filed:
May 28, 2019
Date of Patent:
November 5, 2019
Assignee:
Inscripta, Inc.
Inventors:
Don Masquelier, Phillip Belgrader, Jorge Bernate, Ryan Gill, Kevin Ness
Abstract: The present disclosure provides methods and devices for rapid and efficient modification of a variety of cell types, including mammalian cells, plant cells, archaea, yeasts, and bacteria, by novel methods of introducing exogenous materials, e.g. nucleic acids.
Abstract: The present disclosure relates to methods for control of cell growth rates where cell growth is measured in situ. The methods are applicable to bacterial cells, mammalian cells, non-mammalian eukaryotic cells, plant cells, yeast cells, fungi, and archea.
Abstract: The present disclosure relates to methods and devices for automated control of cell growth rates where cell growth is measured in situ and the devices can be used as a stand-alone device or as a module in an automated environment, e.g., as one module in a multi-station or multi-module cell processing environment. The cell growth device comprises a temperature-controlled vial, a motor assembly to spin the vial, a spectrophotometer for measuring, e.g., OD of the cells in the vial, and a processor to accept input from a user and control the growth rate of the cells.
Abstract: Disclosed herein are nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Disclosed herein are engineered non-naturally occurring nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Targetable nuclease systems can be used to edit genetic targets, including recursive genetic engineering and trackable genetic engineering methods.
Type:
Grant
Filed:
February 14, 2018
Date of Patent:
October 8, 2019
Assignee:
INSCRIPTA, INC.
Inventors:
Ryan T. Gill, Andrew Garst, Tanya Elizabeth Warnecke Lipscomb
Abstract: The present disclosure provides a flow-through electroporation device configured for use as a stand-alone module or as one module in an automated multi-module processing system.
Abstract: In an illustrative embodiment, automated multi-module cell editing instruments are provided to automate multiple edits into nucleic acid sequences inside one or more cells.
Type:
Grant
Filed:
May 14, 2019
Date of Patent:
September 24, 2019
Assignee:
Inscripta, Inc.
Inventors:
Don Masquelier, Phillip Belgrader, Jorge Bernate, Ryan Gill, Kevin Ness
Abstract: In an illustrative embodiment, automated instruments comprising one or more flow-through electroporation devices or modules are provided to automate transformation of nucleic acids in live cells.
Type:
Grant
Filed:
September 30, 2018
Date of Patent:
September 17, 2019
Assignee:
Inscripta, Inc.
Inventors:
Jorge Bernate, Don Masquelier, Phillip Belgrader
Abstract: Disclosed herein are nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Disclosed herein are engineered non-naturally occurring nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Targetable nuclease systems can be used to edit genetic targets, including recursive genetic engineering and trackable genetic engineering methods.
Type:
Grant
Filed:
February 14, 2018
Date of Patent:
July 2, 2019
Assignee:
Inscripta, Inc.
Inventors:
Ryan T. Gill, Andrew Garst, Tanya Elizabeth Warnecke Lipscomb
Abstract: In an illustrative embodiment, automated multi-module cell editing instruments are provided to automate multiple edits into nucleic acid sequences inside one or more cells.
Type:
Grant
Filed:
February 7, 2019
Date of Patent:
June 25, 2019
Assignee:
Inscripta, Inc.
Inventors:
Don Masquelier, Phillip Belgrader, Jorge Bernate, Ryan Gill, Kevin Ness
Abstract: In an illustrative embodiment, automated multi-module cell editing instruments are provided to automate multiple edits into nucleic acid sequences inside one or more cells.
Type:
Grant
Filed:
February 7, 2019
Date of Patent:
June 18, 2019
Assignee:
Inscripta, Inc.
Inventors:
Don Masquelier, Phillip Belgrader, Jorge Bernate, Ryan Gill, Kevin Ness
Abstract: In an illustrative embodiment, automated multi-module cell editing instruments comprising one or more flow-through electroporation devices or modules are provided to automate genome editing in live cells.
Type:
Grant
Filed:
September 30, 2018
Date of Patent:
June 18, 2019
Assignee:
Inscripta, Inc.
Inventors:
Jorge Bernate, Don Masquelier, Phillip Belgrader, Kevin Ness
Abstract: Provided herein are methods and composition for trackable genetic variant libraries. Further provided herein are methods and compositions for recursive engineering. Further provided herein are methods and compositions for multiplex engineering. Further provided herein are methods and compositions for enriching for editing and trackable engineered sequences and cells using nucleic acid-guided nucleases.
Type:
Grant
Filed:
April 9, 2018
Date of Patent:
May 21, 2019
Assignees:
The Regents of the University of Colorado, a body corporate, Inscripta, Inc.
Inventors:
Ryan T. Gill, Andrew Garst, Tanya Elizabeth Warnecke Lipscomb, Marcelo Colika Bassalo, Ramsey Ibrahim Zeitoun
Abstract: Provided herein are methods and composition for trackable genetic variant libraries. Further provided herein are methods and compositions for recursive engineering. Further provided herein are methods and compositions for multiplex engineering. Further provided herein are methods and compositions for enriching for editing and trackable engineered sequences and cells using nucleic acid-guided nucleases.
Type:
Grant
Filed:
April 9, 2018
Date of Patent:
May 14, 2019
Assignees:
The Regents of the University of Colorado, a body corporate, Inscripta, Inc.
Inventors:
Ryan T. Gill, Andrew Garst, Tanya Elizabeth Warnecke Lipscomb, Marcelo Colika Bassalo, Ramsey Ibrahim Zeitoun
Abstract: In an illustrative embodiment, automated multi-module cell editing instruments are provided to automate multiple edits into nucleic acid sequences inside one or more cells.
Type:
Grant
Filed:
June 30, 2018
Date of Patent:
April 9, 2019
Assignee:
INSCRIPTA, INC.
Inventors:
Don Masquelier, Phillip Belgrader, Jorge Bernate, Ryan Gill, Kevin Ness